APTALIS PHARMATECH INC | AbbVie | Ohio | state | 2014 | $159,943 | | grant |
ABBOTT LABORATORIES | Abbott Laboratories | Ohio | state | 2014 | $23,200 | | grant |
PHARMAFORCE INC | Daiichi Sankyo | Ohio | state | 2009 | | $6,000,000 | loan or bond financing |
ABBOTT LABORATORIES | Abbott Laboratories | Ohio | state | 2012 | | $1,500,000 | loan or bond financing |
Boehringer Ingelheim Roxane, Inc.; Roxane Laboratories, Inc. | Hikma Pharmaceuticals | Ohio | local | 2012 | undisclosed | | property tax abatement |
Abbott Laboratories | Abbott Laboratories | Ohio | local | 2019 | $2,530,230 | | tax credit/rebate |
Abbott Laboratories | Abbott Laboratories | Ohio | state | 2019 | undisclosed | | enterprise zone |
Amgen Inc. | Amgen | Ohio | state | 2021 | $15,000,000 | | tax credit/rebate |
Pharmavite LLC | Otsuka Pharmaceutical | Ohio | state | 2022 | $2,080,000 | | tax credit/rebate |
Merck & Co., Inc. | Merck | North Carolina | state | 2008 | $2,940,954 | | tax credit/rebate |
Novo Nordisk Pharmaceuticals | Novo Holdings A/S | North Carolina | state | 2008 | $746,648 | | tax credit/rebate |
Hospira, Inc. | Pfizer | North Carolina | state | 2008 | $537,281 | | tax credit/rebate |
Merck & Co., Inc. | Merck | North Carolina | state | 2008 | $452,785 | | tax credit/rebate |
Hospira, Inc. | Pfizer | North Carolina | state | 2008 | $254,292 | | tax credit/rebate |
Hospira, Inc. | Pfizer | North Carolina | state | 2008 | $200,000 | | tax credit/rebate |
Hospira, Inc. | Pfizer | North Carolina | state | 2008 | $33,750 | | tax credit/rebate |
Biogen Idec US Limited Partnership | Biogen | North Carolina | state | 2009 | $12,564,345 | | tax credit/rebate |
Wyeth Holdings Corporation | Pfizer | North Carolina | state | 2009 | $2,868,194 | | tax credit/rebate |
Hospira, Inc. | Pfizer | North Carolina | state | 2009 | $1,617,030 | | tax credit/rebate |
Merck & Co., Inc. | Merck | North Carolina | state | 2009 | $1,579,355 | | tax credit/rebate |
Novozymes North America, Inc. | Novo Holdings A/S | North Carolina | state | 2009 | $718,878 | | tax credit/rebate |
Novo Nordisk Pharmaceuticals Industries, Inc. | Novo Holdings A/S | North Carolina | state | 2009 | $429,500 | | tax credit/rebate |
Novartis Vaccines & Diagnostics | Novartis | North Carolina | state | 2009 | $74,375 | | tax credit/rebate |
Merck & Co., Inc. | Merck | North Carolina | state | 2010 | $6,007,498 | | tax credit/rebate |
Hospira, Inc. | Pfizer | North Carolina | state | 2010 | $1,665,848 | | tax credit/rebate |
Wyeth Holdings Corporation | Pfizer | North Carolina | state | 2010 | $373,801 | | tax credit/rebate |
Novozymes North America, Inc. | Novo Holdings A/S | North Carolina | state | 2010 | $372,272 | | tax credit/rebate |
Novo Nordisk Pharmaceuticals Industries, Inc. | Novo Holdings A/S | North Carolina | state | 2010 | $270,783 | | tax credit/rebate |
Eisai, Inc. | Eisai | North Carolina | state | 2010 | $203,568 | | tax credit/rebate |
Merck Sharp & Dohme Corp. | Merck | North Carolina | state | 2004 | $5,514,655 | | grant |
Hospira, Inc. | Pfizer | North Carolina | state | 2004 | $1,812,000 | | grant |
Novo Nordisk Pharmaceutical | Novo Holdings A/S | North Carolina | state | 2004 | $1,120,000 | | grant |
GlaxoSmithKline Beecham Corp | GlaxoSmithKline | North Carolina | state | 2005 | $1,859,000 | | grant |
Novartis Vaccines & Diagnostics | Novartis | North Carolina | state | 2006 | $8,015,000 | | grant |
Novartis Vaccines and Diagnostics | Novartis | North Carolina | state | 2010 | $3,609,000 | | grant |
Novo Nordisk Pharmaceutical | Novo Holdings A/S | North Carolina | state | 2010 | $3,032,000 | | grant |
Wyeth Holdings Corporation | Pfizer | North Carolina | state | 2008 | $18,128,934 | | tax credit/rebate |
Novo Nordisk Pharmaceuticals Industries, Inc. | Novo Holdings A/S | North Carolina | state | 2008 | $1,375,593 | | tax credit/rebate |
Merck & Co., Inc. | Merck | North Carolina | state | 2008 | $770,277 | | tax credit/rebate |
Biogen Idec US Limited Partnership | Biogen | North Carolina | state | 2008 | $305,070 | | tax credit/rebate |
Novozymes North America, Inc. | Novo Holdings A/S | North Carolina | state | 2008 | $196,973 | | tax credit/rebate |
Purdue Pharma, LP | Purdue Pharma | North Carolina | state | 2008 | $106,315 | | tax credit/rebate |
Novartis Animal Health US, Inc. | Novartis | North Carolina | state | 2008 | $36,500 | | tax credit/rebate |
Inspire Pharmaceuticals, Inc. | Merck | North Carolina | state | 2008 | $14,500 | | tax credit/rebate |
Wyeth Holdings Corporation | Pfizer | North Carolina | state | 2009 | $1,653,115 | | tax credit/rebate |
Eisai, Inc. | Eisai | North Carolina | state | 2009 | $16,500 | | tax credit/rebate |
Merck & Co., Inc. | Merck | North Carolina | state | 2004 | $24,000,000 | | grant/loan hybrid program |
Hospira, Inc. | Pfizer | North Carolina | state | 2011 | $85,000 | | tax credit/rebate |
Merck & Co., Inc. | Merck | North Carolina | state | 2011 | $55,000 | | tax credit/rebate |
Eisai, Inc. | Eisai | North Carolina | state | 2011 | $15,000 | | tax credit/rebate |
Hospira, Inc. | Pfizer | North Carolina | state | 2011 | $252,000 | | tax credit/rebate |
Merck & Co., Inc. | Merck | North Carolina | state | 2011 | $18,000 | | tax credit/rebate |
Novartis Vaccines & Diagnostics, Inc. | Novartis | North Carolina | state | 2011 | $134,250 | | tax credit/rebate |
Salix Pharmaceuticals, Inc. | Bausch Health | North Carolina | state | 2011 | $15,000 | | tax credit/rebate |
Novozymes North America, Inc. | Novo Holdings A/S | North Carolina | state | 2011 | $649,364 | | tax credit/rebate |
Biogen Idec MA, Inc. | Biogen | North Carolina | state | 2011 | $743,297 | | tax credit/rebate |
Hospira, Inc. | Pfizer | North Carolina | state | 2011 | $344,981 | | tax credit/rebate |
Merck & Co., Inc. | Merck | North Carolina | state | 2011 | $2,774,342 | | tax credit/rebate |
Novartis Vaccines & Diagnostics, Inc. | Novartis | North Carolina | state | 2011 | $6,896,304 | | tax credit/rebate |
Novo Nordisk Pharmaceuticals Industries, Inc. | Novo Holdings A/S | North Carolina | state | 2011 | $214,710 | | tax credit/rebate |
Salix Pharmaceuticals, Inc. | Bausch Health | North Carolina | state | 2011 | $21,024 | | tax credit/rebate |
Amgen USA, Inc. | Amgen | North Carolina | state | 2011 | $2,572 | | tax credit/rebate |
Gilead Palo Alto, Inc. | Gilead Sciences | North Carolina | state | 2011 | $3,743 | | tax credit/rebate |
EMD Serono, Inc. | Merck KGaA (EMD) | North Carolina | state | 2011 | $6,773 | | tax credit/rebate |
Mallinckrodt, Inc. (DE) | Mallinckrodt | North Carolina | state | 2011 | $8,686 | | tax credit/rebate |
Icagen, Inc. | Pfizer | North Carolina | state | 2011 | $9,731 | | tax credit/rebate |
Amgen, Inc. | Amgen | North Carolina | state | 2011 | $20,940 | | tax credit/rebate |
Embrex, Inc. | Pfizer | North Carolina | state | 2011 | $21,304 | | tax credit/rebate |
Serenex, Inc. | Pfizer | North Carolina | state | 2011 | $21,743 | | tax credit/rebate |
Novartis Pharmaceuticals Corporation | Novartis | North Carolina | state | 2011 | $31,277 | | tax credit/rebate |
Furiex Pharmaceuticals, Inc. | AbbVie | North Carolina | state | 2011 | $37,523 | | tax credit/rebate |
Novartis Animal Health US, Inc. | Novartis | North Carolina | state | 2011 | $62,613 | | tax credit/rebate |
Novozymes North America, Inc. | Novo Holdings A/S | North Carolina | state | 2011 | $78,340 | | tax credit/rebate |
Salix Pharmaceuticals, Inc. | Bausch Health | North Carolina | state | 2011 | $96,902 | | tax credit/rebate |
Purdue Pharma, LP | Purdue Pharma | North Carolina | state | 2011 | $123,488 | | tax credit/rebate |
Novo Nordisk, Inc. | Novo Holdings A/S | North Carolina | state | 2011 | $158,503 | | tax credit/rebate |
Eisai, Inc. | Eisai | North Carolina | state | 2011 | $161,293 | | tax credit/rebate |
Wyeth Holdings Corporation | Pfizer | North Carolina | state | 2011 | $189,498 | | tax credit/rebate |
Eli Lilly and Company | Eli Lilly | North Carolina | state | 2011 | $220,883 | | tax credit/rebate |
Novartis Vaccines & Diagnostics, Inc. | Novartis | North Carolina | state | 2011 | $318,349 | | tax credit/rebate |
United Therapeutics Corp | United Therapeutics | North Carolina | state | 2011 | $444,809 | | tax credit/rebate |
Pfizer, Inc. | Pfizer | North Carolina | state | 2011 | $501,793 | | tax credit/rebate |
Gilead Sciences, Inc. | Gilead Sciences | North Carolina | state | 2011 | $550,523 | | tax credit/rebate |
GlaxoSmithkline Holdings Americas , Inc. | GlaxoSmithKline | North Carolina | state | 2011 | $4,039,279 | | tax credit/rebate |
Biogen Idec MA, Inc. | Biogen | North Carolina | state | 2012 | $45,000 | | tax credit/rebate |
Novo Nordisk Pharmaceuticals Industries, Inc. | Novo Holdings A/S | North Carolina | state | 2012 | $49,500 | | tax credit/rebate |
Novo Nordisk Pharmaceuticals Industries, Inc. | Novo Holdings A/S | North Carolina | state | 2012 | $85,700 | | tax credit/rebate |
Novartis Vaccines & Diagnostics, Inc. | Novartis | North Carolina | state | 2012 | $91,500 | | tax credit/rebate |
Merck & Co., Inc. | Merck | North Carolina | state | 2012 | $130,000 | | tax credit/rebate |
Merck & Co., Inc. | Merck | North Carolina | state | 2012 | $160,804 | | tax credit/rebate |
Merck & Co., Inc. | Merck | North Carolina | state | 2012 | $220,500 | | tax credit/rebate |
Novartis Vaccines & Diagnostics, Inc. | Novartis | North Carolina | state | 2012 | $347,213 | | tax credit/rebate |
Mallinckrodt Enterprises | Mallinckrodt | North Carolina | state | 2012 | $441,576 | | tax credit/rebate |
Biogen Idec MA, Inc. | Biogen | North Carolina | state | 2012 | $751,067 | | tax credit/rebate |
Eisai, Inc. | Eisai | North Carolina | state | 2012 | $2,467,398 | | tax credit/rebate |
Merck & Co., Inc. | Merck | North Carolina | state | 2012 | $6,651,352 | | tax credit/rebate |
Amgen USA, Inc. | Amgen | North Carolina | state | 2012 | $3,274 | | tax credit/rebate |
Alpharma Specialty Pharma, Inc. | Pfizer | North Carolina | state | 2012 | $3,885 | | tax credit/rebate |
Mallinckrodt Enterprises Holdings, Inc. | Mallinckrodt | North Carolina | state | 2012 | $3,891 | | tax credit/rebate |
Aerie Pharmaceuticals, Inc. | Aerie Pharmaceuticals | North Carolina | state | 2012 | $5,319 | | tax credit/rebate |
Furiex Pharmaceuticals, Inc. | AbbVie | North Carolina | state | 2012 | $5,602 | | tax credit/rebate |